Literature DB >> 15872045

Antisense phosphorodiamidate morpholino oligomer inhibits viability of Escherichia coli in pure culture and in mouse peritonitis.

Bruce L Geller1, Jesse Deere, Lucas Tilley, Patrick L Iversen.   

Abstract

OBJECTIVES: Antisense phosphorodiamidate morpholino oligomers (PMOs) are synthetic DNA mimics that specifically inhibit gene expression in pure cultures of Escherichia coli. Previously, an 11 base PMO targeted to an essential gene (acpP) for phospholipid biosynthesis was shown to inhibit growth of a pure culture of E. coli AS19, which has an abnormally permeable outer membrane. The objectives of experiments in this report are to show that the AcpP PMO significantly inhibits growth of strain SM105, which has a normal, intact outer membrane, both in pure culture and in infected mice.
METHODS: In pure culture, SM105 was grown in rich broth supplemented with 20 muM AcpP PMO, and growth was monitored by optical density and viable cell count. Mice were infected by intraperitoneal injection with a non-lethal inoculum of either E. coli AS19 or SM105. Following infection, mice were treated intraperitoneally with 300 mug of the 11 base antisense PMO targeted to acpP, a scrambled sequence PMO or PBS.
RESULTS: Growth of SM105 was slower and viable cells were significantly reduced by up to 61% in pure cultures supplemented with AcpP PMO compared with untreated cultures or cultures supplemented with a scrambled sequence PMO. A single dose of AcpP PMO reduced peritoneal cfu of E. coli AS19 about 39- to 600-fold compared with controls at 2, 7, 13 and 23 h after treatment. The same PMO significantly reduced cfu of E. coli SM105 75% compared with controls at 12 h after treatment. However, there was no difference in cfu at 2, 7 or 24 h. A second dose at 24 h again reduced SM105 cfu about 10-fold by 48 h post-infection. In other experiments with infected mice, multiple doses of AcpP PMO sustained the approximately 10-fold reduction in SM105 cfu at 6, 12 and 24 h post-infection. Compared with equivalent (micromolar) doses of ampicillin, AcpP PMO was significantly more effective at all time points. Specificity of PMO inhibition was shown in other experiments by treating infected mice with a PMO targeted to a non-essential reporter gene for luciferase. A luciferase-specific PMO reduced both the amount and activity of luciferase to the same extent, whereas scrambled PMO had no effect.
CONCLUSIONS: An 11 base antisense PMO targeted to acpP significantly inhibited viability of a strain of E. coli with a normal, intact outer membrane both in pure culture and in infected mice. Inhibition by PMOs was sequence-specific.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15872045     DOI: 10.1093/jac/dki129

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  29 in total

1.  Gene-specific effects of antisense phosphorodiamidate morpholino oligomer-peptide conjugates on Escherichia coli and Salmonella enterica serovar typhimurium in pure culture and in tissue culture.

Authors:  Lucas D Tilley; Orion S Hine; Jill A Kellogg; Jed N Hassinger; Dwight D Weller; Patrick L Iversen; Bruce L Geller
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

Review 2.  Fighting against evolution of antibiotic resistance by utilizing evolvable antimicrobial drugs.

Authors:  Mehmet Fatih Cansizoglu; Erdal Toprak
Journal:  Curr Genet       Date:  2017-05-11       Impact factor: 3.886

3.  Antimicrobial activity of antisense peptide-peptide nucleic acid conjugates against non-typeable Haemophilus influenzae in planktonic and biofilm forms.

Authors:  Taketo Otsuka; Aimee L Brauer; Charmaine Kirkham; Erin K Sully; Melinda M Pettigrew; Yong Kong; Bruce L Geller; Timothy F Murphy
Journal:  J Antimicrob Chemother       Date:  2016-09-28       Impact factor: 5.790

4.  Antisense phosphorodiamidate morpholino oligomers targeted to an essential gene inhibit Burkholderia cepacia complex.

Authors:  David E Greenberg; Kimberly R Marshall-Batty; Lauren R Brinster; Kol A Zarember; Pamela A Shaw; Brett L Mellbye; Patrick L Iversen; Steven M Holland; Bruce L Geller
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

5.  (99m)Tc-MORF oligomers specific for bacterial ribosomal RNA as potential specific infection imaging agents.

Authors:  Ling Chen; Yi Wang; Dengfeng Cheng; Xinrong Liu; Shuping Dou; Guozheng Liu; Donald J Hnatowich; Mary Rusckowski
Journal:  Bioorg Med Chem       Date:  2013-08-28       Impact factor: 3.641

6.  Peptide conjugated phosphorodiamidate morpholino oligomers increase survival of mice challenged with Ames Bacillus anthracis.

Authors:  Rekha G Panchal; Bruce L Geller; Brett Mellbye; Douglas Lane; Patrick L Iversen; Sina Bavari
Journal:  Nucleic Acid Ther       Date:  2012-09-14       Impact factor: 5.486

7.  Comparison of microplate and macrodilution methods in time-kill study of new antimicrobial drugs.

Authors:  Ying Zhou; Zheng Hou; Chao Fang; Xiaoyan Xue; Fei Da; Yukun Wang; Hui Bai; Xiaoxing Luo
Journal:  Folia Microbiol (Praha)       Date:  2012-06-09       Impact factor: 2.099

8.  Improved templated fluorogenic probes enhance the analysis of closely related pathogenic bacteria by microscopy and flow cytometry.

Authors:  Raphael M Franzini; Eric T Kool
Journal:  Bioconjug Chem       Date:  2011-08-26       Impact factor: 4.774

9.  Bacterial resistance to antisense peptide phosphorodiamidate morpholino oligomers.

Authors:  Susan E Puckett; Kaleb A Reese; Georgi M Mitev; Valerie Mullen; Rudd C Johnson; Kyle R Pomraning; Brett L Mellbye; Lucas D Tilley; Patrick L Iversen; Michael Freitag; Bruce L Geller
Journal:  Antimicrob Agents Chemother       Date:  2012-09-17       Impact factor: 5.191

10.  Novel anion liposome-encapsulated antisense oligonucleotide restores susceptibility of methicillin-resistant Staphylococcus aureus and rescues mice from lethal sepsis by targeting mecA.

Authors:  Jingru Meng; Hui Wang; Zheng Hou; Tao Chen; Jingguo Fu; Xue Ma; Gonghao He; Xiaoyan Xue; Min Jia; Xiaoxing Luo
Journal:  Antimicrob Agents Chemother       Date:  2009-05-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.